Evaluation of Imiquimod 5% Cream to Modify the Natural History of Herpes Labialis: A Pilot Study
Open Access
- 15 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (6) , 808-814
- https://doi.org/10.1086/432802
Abstract
Background. Imiquimod is currently approved for the treatment of genital warts and has been shown to decrease recurrences of genital herpes in the guKeywords
This publication has 21 references indexed in Scilit:
- Treatment of herpes simplex virus infectionsPublished by Elsevier ,2003
- Application of a Topical Immune Response Modifier, Resiquimod Gel, to Modify the Recurrence Rate of Recurrent Genital Herpes: A Pilot StudyThe Journal of Infectious Diseases, 2001
- Daily or Weekly Therapy with Resiquimod (R‐848) Reduces Genital Recurrences in Herpes Simplex Virus–Infected Guinea Pigs during and after TreatmentThe Journal of Infectious Diseases, 2001
- Imiquimod 5% cream (Aldara™)Expert Opinion on Investigational Drugs, 1998
- Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigsAntimicrobial Agents and Chemotherapy, 1994
- Suppression of Recurrent Genital Herpes Simplex Virus Infection with Recombinant 2 InterferonThe Journal of Infectious Diseases, 1986
- Risk of Recurrence after Treatment of First-episode Genital Herpes with Intravenous AcyclovirSexually Transmitted Diseases, 1985
- A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus InfectionNew England Journal of Medicine, 1984
- Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virusVirus Research, 1984
- The Role of Interferon in the Resistance of CS7BL/6 Mice to Various Doses of Herpes Simplex Virus Type 1The Journal of Infectious Diseases, 1982